« Back
Home /
MOUSE ANTI HUMAN CD98:FITC

MOUSE ANTI HUMAN CD98:FITC

Manufacturer	GENWAY
Category	Oncology Antibodies Primary Antibodies By Organ Testicular & Prostate Cancer
Type	Antibody
Specific against	Human
Amount	0.02 mg
Host	Mouse
Item no.	20-783-314897
eClass 6.1	32160702
eClass 9.0	32160702
Available
Genway ID:	GWB-61A3C6
Specificity:	CD98
Isotype:	IgG1
Preparation:	Purified IgG prepared by affinity chromatography on Protein G
Buffer Solution:	Phosphate buffered saline
Preservative Stabilisers:		0. 09% Sodium Azide 1% Bovine Serum AlbuminApprox. Protein Concentrations: IgG concentration 0. 1 mg/ml
Immunogen:	HOON pre-B leukaemia cell line.
Specificity:	Reacts with the heavy chain of the CD98 molecule. The epitope is distinct from clone 44H7 but the same as recognised by 4F2. This antibody binds to all cell lines in culture and to activated T-cells. Recommended Negative Controls: MOUSE IgG1 NEGATIVE CONTROL:FITC
Function:	Required for the function of light chain amino-acid transporters. Involved in sodium-independent high-affinity transport of large neutral amino acids such as phenylalanine tyrosine leucine arginine and tryptophan. Involved in guiding and targeting of LAT1 and LAT2 to the plasma membrane. When associated with SLC7A6 or SLC7A7 acts as an arginine/glutamine exchanger following an antiport mechanism for amino acid transport influencing arginine release in exchange for extracellular amino acids. Plays a role in nitric oxide synthesis in human umbilical vein endothelial cells (HUVECs) via transport of L-arginine. Required for normal and neoplastic cell growth. When associated with SLC7A5/LAT1 is also involved in the transport of L-DOPA across the blood-brain barrier and that of thyroid hormones triiodothyronine (T3) and thyroxine (T4) across the cell membrane in tissues such as placenta. Involved in the uptake of methylmercury (MeHg) when administered as the L-cysteine or D L-homocysteine complexes and hence plays a role in metal ion homeostasis and toxicity. When associated with SLC7A5 or SLC7A8 involved in the cellular activity of small molecular weight nitrosothiols via the stereoselective transport of L-nitrosocysteine (L-CNSO) across the transmembrane. Together with ICAM1 regulates the transport activity LAT2 in polarized intestinal cells by generating and delivering intracellular signals. When associated with SLC7A5 plays an important role in transporting L-leucine from the circulating blood to the retina across the inner blood-retinal barrier. Ref. 6Ref. 12Ref. 13Ref. 14Ref. 15Ref. 16Ref. 17Ref. 19Ref. 20Ref. 22Ref. 23Ref. 25Ref. 26Ref. 28Ref. 29Subunit structureDisulfide-linked heterodimer of a glycosylated heavy chain and a non-glycosylated light chain (SLC7A5 SLC7A6 SLCA7A7 SLC7A8 SLC7A10 or SLCA7A11). Colocalizes with cadherins By similarity. Interacts with FAM57A/CT120 and ICAM1. Constitutively and specifically associates with beta-1 integrins (alpha-2/beta-1 alpha-3/beta-1 alpha-5/beta-1 and alpha-6/beta-1) but minimally with alpha-4/beta-1. Ref. 6Ref. 12Ref. 13Ref. 14Ref. 16Ref. 17Ref. 19Ref. 23Ref. 25Ref. 26Ref. 29Ref. 18Ref. 21Ref. 40Subcellular locationApical cell membrane; Single-pass type II membrane protein. Melanosome.
Note:	Identified by mass spectrometry in melanosome fractions from stage I to stage IV. Localized to the plasma membrane when associated with SLC7A5 or SLC7A8. Localized to the placental apical membrane. Located selectively at cell-cell adhesion sites By similarity. Colocalized with SLC7A8/LAT2 at the basolateral membrane of kidney proximal tubules and small intestine epithelia. Expressed in both luminal and abluminal membranes of brain capillary endothelial cells By similarity. Ref. 16Ref. 17Ref. 20Ref. 23Ref. 26Ref. 40Ref. 32Ref. 33Tissue specificityExpressed ubiquitously in all tissues tested with highest levels detected in kidney placenta and testis and weakest level in thymus. During gestation expression in the placenta was significantly stronger at full-term than at the mid-trimester stage. Expressed in HUVECS and at low levels in resting peripheral blood T-lymphocytes and quiescent fibroblasts. Also expressed in fetal liver and in the astrocytic process of primary astrocytic gliomas. Expressed in retinal endothelial cells and in the intestinal epithelial cell line Caco2-BBE. Ref. 6Ref. 17Ref. 20Ref. 25Ref. 26Ref. 28Ref. 32Ref. 4Ref. 5Induction: Expression is induced in resting peripheral blood T-lymphocytes following PHA stimulation. Expression increases at the time of maximal DNA synthesis in fibroblasts stimulated to divide. Expression and the uptake of leucine is stimulated in mononuclear cytotrophoblast-like choriocarcinoma cells by combined treatment with PMA and calcium ionophore. Ref. 20Ref. 4Ref. 5Post-translational modificationPhosphorylation on Ser-406; Ser-408 or Ser-410 and on Ser-527 or Ser-531 by ecto-protein kinases favors heterotypic cell-cell interactions.
Miscellaneous:	Arginine uptake is inhibited by increasing concentrations of leucine in the presence of Na+. Sequence similaritiesBelongs to the SLC3A transporter family. Biophysicochemical properties Kinetic parameters:KM=295 & micro; M for glutamine (in the presence of NaCl) Ref. 15KM=236 & micro; M for leucine (in the presence of NaCl)KM=120 & micro; M for arginine (in the presence of NaCl)KM=138 & micro; M for arginine (in the absence of NaCl)Mass spectrometryMolecular mass is 57944. 93 Da from positions 1 - 529. Determined by MALDI. Ref. 24

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 0.02 mg

available

Delivery expected until 5/30/2024